Amber Therapeutics
London
About Amber Therapeutics
Amber Therapeutics develops the next-generation of bioelectrical therapies that can sense and adapt as well as stimulate, with the potential to radically improve clinical outcomes in patients with functional disorders of the peripheral nervous system.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $103.1M
- Funding stage: Early Stage Venture
- Last round: Non-Equity Assistance (Mar 2026)
- Website: amber-tx.com
Industries & Categories
Biotechnology, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/amber-therapeutics-98145 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.